青春期妇科马斯蒂亚的塔莫西芬治疗:何时开始和持续多长时间
Elif Sabancı1, Melis Pehlivantürk-Kızılkan2, Sinem Akgül2
1Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Breast care (Basel, Switzerland)
|October 30, 2023
概括
在青少年中,治疗青春期妇科马斯蒂亚的塔莫西芬是有效和安全的. 这项研究建议6个月的治疗时间和3厘米的圆盘直径值,以获得最佳的治疗结果.
科学领域:
- 儿科内分泌学 儿科内分泌学
- 青少年医学 青少年医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 青春期妇产不适是青少年男性的常见疾病,通常会自发消失.
- 塔莫西芬是青春期妇产不适的特定病例的推治疗选择.
研究的目的:
- 评估塔莫西芬在治疗青少年青春期妇产的适用性,安全性和有效性.
- 为了确定最佳的治疗持续时间和开始他莫西芬治疗的标准.
主要方法:
- 对83名青少年进行了回顾性分析,这些青少年患有青春期性妇联,接受了他莫西芬治疗 (2006-2018).
- 评估临床数据,治疗指示,剂量,持续时间和结果.
- 分析了妇产不适的圆盘直径减小率.
主要成果:
- 塔莫西芬治疗在减少妇产性椎间盘直径方面表现出显著的有效性.
- 初始圆盘直径≥3厘米的青少年经历了更高的每月减少率.
- 在治疗4-6个月后观察到最佳的盘缩小.
结论:
- 塔莫西芬是一种有效和安全的治疗青少年青春期妇产不适.
- 该研究建议治疗时间至少为6个月,以获得最佳结果.
- 建议在开始他莫西芬治疗时,磁盘直径值≥3厘米.
相关概念视频
Signs of Puberty
375
Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
375
Menopause
175
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
175
Hormonal Regulation of the Menstrual Cycle
408
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
408
Dosage Regimen: Fixed Dose
1.9K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.9K
Drug Dosage Regimen: Overview
3.6K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.6K
Myocarditis IV: Nursing Management
13
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
13


